Effect of vitamins A, C, and e supplementation in the treatment of metabolic syndrome in albino rats

Biochemistry Research International

Volumn , Issue , 2012, Pages

  Bilbis, L S ^a   Muhammad, S A ^a   Saidu, Y ^a   Adamu, Y ^a  

^a USMANU DANFODIYO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

EID: 84866245772     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2012/678582     Document Type: Article

References (48)

1. Lakka H. M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., Salonen J. T., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 2002 288 21 2709 2716 2-s2.0-0037021505 10.1001/jama.288.21. 2709 (Pubitemid 35403784)
2. Haffner S., Taegtmeyer H., Epidemic obesity and the metabolic syndrome. Circulation 2003 108 13 1541 1545 2-s2.0-0141506880 10.1161/01.CIR.0000088845. 17586.EC (Pubitemid 37187777)
3. Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., Gordon D. J., Krauss R. M., Savage P. J., Smith S. C., Spertus J. A., Costa F., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005 112 17 2735 2752 2-s2.0-27444443876 10.1161/CIRCULATIONAHA.105.169404 (Pubitemid 41532612)
4. Doelle G. C., The clinical picture of metabolic syndrome: an update on this complex of conditions and risk factors. Postgraduate Medicine 2004 116 1 30 38 2-s2.0-3042723900 (Pubitemid 38886681)
5. Schillaci G., Pirro M., Vaudo G., Gemelli F., Marchesi S., Porcellati C., Mannarino E., Prognostic value of the metabolic syndrome in essential hypertension. Journal of the American College of Cardiology 2004 43 10 1817 1822 2-s2.0-2442491085 10.1016/j.jacc.2003.12.049 (Pubitemid 38622521)
6. Aparil S., Metabolic syndrome: the disease of the new millennium. Baylor College of Medicine 2006 4, article 4
7. Park Y. W., Zhu S., Palaniappan L., Heshka S., Carnethon M. R., Heymsfield S. B., The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 19881994. Archives of Internal Medicine 2003 163 4 427 436 2-s2.0-0037463608 10.1001/archinte.163.4.427 (Pubitemid 36241019)
8. Gerald R., The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinology and Metabolism Clinics of North America 2004 33 2 283 303 2-s2.0-2542424815 10.1016/j.ecl.2004.03.002 (Pubitemid 38680631)
9. Darwin D., Albert E., Metabolic syndrome: time for action. American Family Physician 2004 69 12 2875 2887 2-s2.0-3042700220
10. Kjeldsen S. E., Naditch-Brule L., Perlini S., Zidek W., Farsang C., Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. Journal of Hypertension 2008 26 10 2064 2070 2-s2.0-58149116671 10.1097/HJH.0b013e32830c45c3
11. Misra A., Khurana L., Obesity and the metabolic syndrome in developing countries. Journal of Clinical Endocrinology and Metabolism 2008 93 11 s9 s30 2-s2.0-55849137212 10.1210/jc.2008-1595
12. Motala A. A., Esterhuizen T., Gouws E., Pirie F. J., Mahomed A. K., Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care 2008 31 9 1783 1788 2-s2.0-54349127534 10.2337/dc08-0212
13. Shirai K., Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Current Medical Research and Opinion 2004 20 3 295 304 2-s2.0-1542720650 10.1185/030079903125003008 (Pubitemid 38339170)
14. Franklin S. S., Hypertension in the metabolic syndrome. Metabolic Syndrome and Related Disorders 2006 4 4 287 298 2-s2.0-33846558996 10.1089/met.2006.4.287 (Pubitemid 46157508)
15. Miyajima K., Minatoguchi S., Ito Y., Hukunishi M., Matsuno Y., Kakami M., Kawasaki M., Nishigaki K., Takemura G., Fujiwara H., Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension. Hypertension Research 2007 30 4 307 313 2-s2.0-34249080316 10.1291/hypres.30.307 (Pubitemid 46779979)
16. John S., Schmieder R., Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Current Hypertension Reports 2003 5 3 199 207 2-s2.0-3142750573 (Pubitemid 38914962)
17. Hoagland K. M., Maier K. G., Roman R. J., Contributions of 20-HETE to the antihypertensive effects of tempol in Dahl salt-sensitive rats. Hypertension 2003 41 3 697 702 2-s2.0-0037342599 10.1161/01.HYP.0000047881.15426.DC (Pubitemid 36314577)
18. Duffy S. J., Gokce N., Holbrook M., Hunter L. M., Biegelsen E. S., Huang A., Keaney J. F., Vita J. A., Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. American Journal of Physiology 2001 280 2 H528 H534 2-s2.0-0035013889
19. Boshtam M., Rafiei M., Sadeghi K., Sarraf-Zadegan N., Vitamin E can reduce blood pressure in mild hypertensives. International Journal for Vitamin and Nutrition Research 2002 72 5 309 314 2-s2.0-0036807479 (Pubitemid 35337174)
20. Trinder P., Determination of blood glucose using 4-amino phenazone as oxygen acceptor. Journal of Clinical Pathology 1969 6 2 24 25 2-s2.0-0014481680
21. Allain C. C., Poon L. S., Chan C. S. G., Enzymatic determination of total serum cholesterol. Clinical Chemistry 1974 20 4 470 475 2-s2.0-0016373654
22. Tietz N. W., Serum triglyceride determination. Clinical Guide to Laboratory Tests 1990 2nd Philadelphia, Pa, USA W.B. Saunders 554 556
23. Burstein M., Scholnick H. R., Morfin R., Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Journal of Lipid Research 1970 11 6 583 595 2-s2.0-0014876627
24. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
25. Abbott R. D., Wilson P. W. F., Kannel W. B., Castelli W. P., High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 1988 8 3 207 211 2-s2.0-0023880042
26. Hashim S. A., Schuttringer G. R., Rapid determination of tocopherol in marco- and microquantities of plasma. Results obtained in various nutrition and metabolic studies. American Journal of Clinical Nutrition 1966 19 2 137 145 2-s2.0-0013941741
27. Natelson S., Determination of Ascorbic acid using 2, 4- Dinitrophenyl hydrazine. Technique of Clinical Chemistry 1971 3rd New York, NY, USA Charles C. Thomas, Spring Field 165 166
28. Koracevic D., Koracevic G., Djordjevic V., Andrejevic S., Cosic V., Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology 2001 54 5 356 361 2-s2.0-0035008460 10.1136/jcp.54.5.356 (Pubitemid 32458132)
29. Niehaus W. G., Samuelsson B., Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. European Journal of Biochemistry 1968 6 1 126 130 2-s2.0-0014421644
30. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
31. Chen X., Touyz R. M., Park J. B., Schiffrin E. L., Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001 38 3 606 611 2-s2.0-0035460097
32. Maharjan B. R., Jha J. C., Adhikari D., Vishwanath P., Baxi J., Alurkar V. M., Singh P. P., A study of oxidative stress, antioxidant status and lipid profile in diabetic patient in the western region of Nepal. Kathmandu University Medical Journal 2008 6 1 63 68 2-s2.0-58149180266
33. Saha M. S., Sana N. K., Ranajit K. S., Serum lipid profile of hypertensive patients in the Northern region of Bangladesh. Journal of Bioscience 2006 14 93 98
34. Biswas U. K., Kumar A., A study on lipid profile, oxidation stress and carbonic anhydrase activity in patients with essential hypertension. Journal of Clinical and Diagnostic Research 2010 4 6 3414 3420 2-s2.0-78650573914
35. Brehm A., Pfeiler G., Pacini G., Vierhapper H., Roden M., Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clinical Chemistry 2004 50 12 2316 2322 2-s2.0-9244255852 10.1373/clinchem.2004.037556 (Pubitemid 39552167)
36. Brinton E. A., Controversies in dyslipidemias: atheroprevention in diabetes and insulin resistance. Annals of the New York Academy of Sciences 2005 1055 159 178 2-s2.0-32244442963 10.1196/annals.1323.024 (Pubitemid 43211670)
37. Després J. P., Lamarche B., Mauriège P., Cantin B., Dagenais G. R., Moorjani S., Lupien P. J., Hyperinsulinemia as an independent risk factor for ischemic heart disease. The New England Journal of Medicine 1996 334 15 952 957 2-s2.0-0029862973 10.1056/NEJM199604113341504 (Pubitemid 26114161)
38. Lehto S., Rönnemaa T., Pyörälä K., Laakso M., Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes. Diabetologia 2000 43 2 148 155 2-s2.0-0034002064 (Pubitemid 30126818)
39. Somers M. J., Mavromatis K., Galis Z. S., Harrison D. G., Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000 101 14 1722 1728 2-s2.0-0034636125 (Pubitemid 30196634)
40. Larrousse M., Bragulat E., Segarra M., Sierra C., Coca A., de La Sierra A., Increased levels of atherosclerosis markers in salt-sensitive hypertension. American Journal of Hypertension 2006 19 1 87 93 2-s2.0-32344445991 10.1016/j.amjhyper.2005.06.019 (Pubitemid 43217040)
41. Gopaul N. K., Manraj M. D., Hébé A., Lee Kwai Yah S., Johnston A., Carrier M. J., Änggård E. E., Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 2001 44 6 706 712 2-s2.0-0034857939 10.1007/s001250051679 (Pubitemid 32846025)
42. Esper R. J., Nordaby R. A., Vilariño J. O., Paragano A., Cacharrón J. L., Machado R. A., Endothelial dysfunction: a comprehensive appraisal. Cardiovascular Diabetology 2006 5, article 4 2-s2.0-33645755859 10.1186/1475-2840-5-4
43. Sonnenberg G. E., Krakower G. R., Kissebah A. H., A novel pathway to the manifestations of metabolic syndrome. Obesity Research 2004 12 2 180 186 2-s2.0-2942698938 (Pubitemid 41132540)
44. Baron A. D., Clark M. G., Role of blood flow in the regulation of muscle glucose uptake. Annual Review of Nutrition 1997 17 487 499 2-s2.0-0030839740 10.1146/annurev.nutr.17.1.487 (Pubitemid 27328810)
45. Ogihara T., Asano T., Ando K., Sakoda H., Anai M., Shojima N., Ono H., Onishi Y., Fujishiro M., Abe M., Fukushima Y., Kikuchi M., Fujita T., High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 2002 40 1 83 89 2-s2.0-0036318323 10.1161/01.HYP.0000022880.45113.C9 (Pubitemid 34755984)
46. Toshiro F., Insulin resistance and salt-sensitive hypertension in metabolic syndrome. Nephrology Dialysis Transplantation 2007 22 11 3102 3107 2-s2.0-36749078620 10.1093/ndt/gfm409 (Pubitemid 350214012)
47. Baker T. A., Milstien S., Katusic Z. S., Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. Journal of Cardiovascular Pharmacology 2001 37 3 333 338 2-s2.0-0035120543 10.1097/00005344-200103000-00012 (Pubitemid 32193512)
48. Heller R., Werner-Felmayer G., Werner E. R., Antioxidants and endothelial nitric oxide synthesis. European Journal of Clinical Pharmacology 2006 62 13 21 28 2-s2.0-33344463217 10.1007/s00228-005-0009-7